Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Chronic liver diseases (CLDs) encompass a wide range of illnesses, including nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and viral hepatitis. Deterioration of liver capacity, with subsequent progression into cirrhosis and hepatocellular carcinoma (HCC), ultimately leads to a furt...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Hepatocell Carcinoma
Asıl Yazarlar: Abdel-Wahab, Reham, Shehata, Samir, Hassan, Manal M, Habra, Mouhammed A, Eskandari, Ghazaleh, Tinkey, Peggy T, Mitchell, Jennifer, Lee, Ju-Seog, Amin, Hesham M, Kaseb, Ahmed O
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918293/
https://ncbi.nlm.nih.gov/pubmed/27508202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S81309
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller